| Overview |
| bsm-90296r-50µL |
| Exo/Endonuclease G Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ENDOGL1 / ENGL |
| 350-368/368 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 9941 |
| Q9Y2C4 |
| Exo/Endonuclease G; ENGL; Endonuclease G-Like 1; ENDOGL1; ENDOGL2; ENGL-A; ENGL-B; Endo/Exonuclease (5'-3') Endonuclease G-Like; Nuclease EXOG Mitochondrial; Endonuclease G-Like 2; Endo G-Like 1; EC 3.1.30.-; EC 3.1.30; ENGLA; ENGLB |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |